James C. Mullen
2007
In 2007, James C. Mullen earned a total compensation of $10.6M as President and CEO at Biogen.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $67,817 |
|---|---|
| Non-Equity Incentive Plan | $1,943,500 |
| Option Awards | $3,790,983 |
| Salary | $1,142,308 |
| Stock Awards | $3,441,900 |
| Other | $210,786 |
| Total | $10,597,294 |
Mullen received $3.8M in option awards, accounting for 36% of the total pay in 2007.
Mullen also received $67.8K of change in pension value and nonqualified deferred compensation earnings, $1.9M in non-equity incentive plan, $1.1M in salary, $3.4M in stock awards and $210.8K in other compensation.
Rankings
In 2007, James C. Mullen's compensation ranked 264th out of 8,700 executives tracked by ExecPay. In other words, Mullen earned more than 97.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 264 out of 8,700 | 97th |
Division Manufacturing | 75 out of 3,314 | 98th |
Major group Chemicals And Allied Products | 16 out of 746 | 98th |
Industry group Drugs | 11 out of 546 | 98th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 118 | 98th |
Source: SEC filing on April 28, 2010.
Mullen's colleagues
We found two more compensation records of executives who worked with James C. Mullen at Biogen in 2007.